US equities
|
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SPCX
$158.96
▲+0.00%
AMD
$633.91
▲+0.00%
WDC
$415.29
▲+0.00%
TSLA
$370.59
▲+0.00%
INTC
$119.13
▼-0.17%
MU
$1,074.89
▲+0.00%
NVDA
$233.95
▲+0.00%
SNDK
$1,719.99
▲+0.00%
SPCX
$158.96
▲+0.00%
AMD
$633.91
▲+0.00%
WDC
$415.29
▲+0.00%
TSLA
$370.59
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Jupiter Wellness, Inc. - Common Stock
(NQ:
JUPW
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 14, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Jupiter Wellness, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
16 Stocks Moving in Friday's Pre-Market Session
↗
April 08, 2022
Gainers Biofrontera Inc. (NASDAQ: BFRI) rose 34.5% to $5.44 in pre-market trading. ENDRA Life Sciences Inc. (NASDAQ: NDRA) rose 31.9% to $0.5891 in pre-market trading after...
Via
Benzinga
Jupiter Wellness to Launch CaniSun for Shark Defense Sunscreen with Patented Shark Repellents
April 07, 2022
Exclusive Worldwide Rights to Patented Shark Repellent Technologies for the Sun and Skin Market Licensed From Shark Defense Technologies, the Leader in Its Field Featured in Numerous Media Outlets...
From
Jupiter Wellness, Inc.
Via
AccessWire
Article "Novel Cannabidiol Aspartame Combination Treatment (JW-100) Significantly Reduces ISGA Score in Atopic Dermatitis: Results From a Randomized Double-Blinded Placebo-Controlled Interventional Study" Published in Journal of Cosmetic Dermatology
April 06, 2022
Authored by an International Group of Leading Dermatology Researchers and Clinicians Who Conducted the Studies JUPITER, FL / ACCESSWIRE / April 6, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW), today...
From
Jupiter Wellness, Inc.
Via
AccessWire
Jupiter Wellness Launches NoStingz Jellyfish Protective Sunscreen Backed by Patent-Pending Formula in $13 B Sunscreen Market
April 05, 2022
- Jupiter licenses exclusive worldwide rights for unique formulas addressing jellyfish and man o' war stings, sea lice, and swimmer's itch with 4 patents-pending - Estimated 150 million people are...
From
Jupiter Wellness, Inc.
Via
AccessWire
Topics
Intellectual Property
64 Biggest Movers From Friday
↗
March 28, 2022
Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) shares surged 143% to settle at $3.84 on Friday after the company reported better-than-expected Q4 sales results and reaffirmed...
Via
Benzinga
34 Stocks Moving in Friday's Pre-Market Session
↗
March 25, 2022
Gainers Clever Leaves Holdings Inc. (NASDAQ: CLVR) rose 40.5% to $2.22 in pre-market trading after the company reported better-than-expected Q4 sales results and reaffirmed FY22...
Via
Benzinga
12 Consumer Staples Stocks Moving In Monday's After-Market Session
↗
March 14, 2022
Gainers Eastside Distilling (NASDAQ:EAST) shares rose 9.1% to $1.05 during Monday's after-market session. The company's market cap stands at $16.6 million.
Via
Benzinga
Jupiter Wellness Completes Enrollment in Double-Blind Placebo-Controlled Clinical Trial of JW-200 for the Treatment of Actinic Keratosis
February 18, 2022
Data expected Q1 2022 on efficacy of JW-200 to clear AK lesions, a common form of pre-cancerous growth that left untreated can lead to cancer in up to 15% of patients JUPITER, FL / ACCESSWIRE /...
From
Jupiter Wellness, Inc.
Via
AccessWire
Jupiter Wellness Merger Partner Next Frontier's Executive Chairman Shannon Soqui Interview with Benzinga
February 15, 2022
JUPITER, FL / ACCESSWIRE / February 15, 2022 / Jupiter Wellness, Inc. (Nasdaq:JUPW) today announced that its merger partner Next Frontier Pharmaceuticals' Executive Chairman Shannon Soqui was...
From
Jupiter Wellness, Inc.
Via
AccessWire
Benzinga Announces This Week's All Access Guests
↗
February 10, 2022
Benzinga is thrilled to announce the guest lineup for our next All Access show, sponsored by TiiCKER, set to air Friday, February 11 at 9:15 am ET. The Lineup 9:15 am...
Via
Benzinga
Jupiter Wellness’ CEO Brian John & Next Frontier’s Executive Chairman Shannon Soqui Interviewed on SNN Network
February 02, 2022
Corporate Presentation Highlights Merged Company's Strength as Leading Drug Developer Focused on Pharma Cannabinoids: LINK JUPITER, FL / ACCESSWIRE / February 2, 2022 / Jupiter Wellness, Inc....
From
Jupiter Wellness, Inc.
Via
AccessWire
Jupiter Wellness' Merger Partner Next Frontier Pharmaceuticals, Inc. Announces Plans for Oral Dronabinol Solution for the Treatment of Alzheimer's Disease Agitation
February 01, 2022
- Next Frontier Pharmaceuticals is pursuing FDA 505(b)(2) fast-track approval with its previously FDA approved oral dronabinol (THC) solution - Next Frontier Pharmaceuticals has completed a pre-IND...
From
Jupiter Wellness, Inc.
Via
AccessWire
The Week In Cannabis: Amazon Supports Legalization, NY Expands Its Medical Program, Stocks Underperform And More
↗
January 28, 2022
Below is a recap of the main news related to the cannabis industry and markets for the week of January 24, 2022. Contents
Via
Benzinga
Jupiter Wellness Announces Board Approval of $5.0 Million Share Buyback Program
January 25, 2022
Represents Approximately 30% of Jupiter Wellness's Outstanding Shares at current market price JUPITER, FL / ACCESSWIRE / January 25, 2022 / Jupiter Wellness, Inc. (NASDAQ:JUPW) today announced it its...
From
Jupiter Wellness, Inc.
Via
AccessWire
Jupiter Wellness To Dividend SRM Entertainment Subsidiary To Its Stockholders
↗
January 24, 2022
Jupiter Wellness, Inc. (NASDAQ:JUPW) revealed
Via
Benzinga
Jupiter Wellness to Dividend SRM Entertainment Subsidiary to its Stockholders
January 24, 2022
SRM Entertainment to raise up to $10 million and seek listing on Nasdaq Creates a "Pure Play" Drug Developer in Jupiter Wellness upon the Completion of its Pending Merger with Next Frontier...
From
Jupiter Wellness, Inc.
Via
AccessWire
Jupiter Wellness' Merger Partner Next Frontier Pharmaceuticals, Inc. Enters Psychedelic Drug Development and API Market
January 20, 2022
Next Frontier Pharmaceuticals' Subsidiary Benuvia Signs Agreement with Global Wellness' Shanti Therapeutics - Benuvia has begun focusing on Psilocybin, DMT, and MDMA. - Benuvia's 83,000 square foot...
From
Jupiter Wellness, Inc.
Via
AccessWire
Jupiter Wellness Issues Letter to Stockholders
January 10, 2022
JUPITER, FL / ACCESSWIRE / January 10, 2022 / Jupiter Wellness Issues Letter to Stockholders: Dear Fellow Stockholders, Jupiter Wellness, Inc. ("Jupiter", or the "Company"), has, we believe,...
From
Jupiter Wellness, Inc.
Via
AccessWire
52 Weeks High And Low Article
↗
January 11, 2022
Stocks that Broke Yearly Lows Tuesday Morning During Tuesday's morning trading, 87 companies set new 52-week lows. Noteworthy Highlights From Today's 52-Week Highs And Lows: 10x...
Via
Benzinga
Are Cannabinoids the Next Frontier of Pharmaceuticals? This Company Thinks So and Wants to Lead the Pack
↗
December 14, 2021
Photo by Michael Longmire on...
Via
Benzinga
Jupiter (JUPW) Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Jupiter Wellness, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – JUPW
December 11, 2021
From
Halper Sadeh LLP
Via
Business Wire
The Week In Cannabis: Isiah Thomas, Tilray, The DEA, Ohio, Mexico And More
↗
December 10, 2021
Below is a recap of the main news related to the cannabis industry and markets for the week of December 6, 2021.
Via
Benzinga
Topics
Cannabis
The Link Between Cannabis Consumption and Sleep — Cannabis Daily December 10, 2021
↗
December 10, 2021
The Best Daily Overview Of The Cannabis Space Governor of Kentucky looking to legalize medical marijuana in the coming legislativ...
Via
Benzinga
Topics
Cannabis
Jupiter Wellness Just Reported A Big Move In Pharma
↗
December 10, 2021
Image provided by Jupiter Wellness of their new lab. The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content...
Via
Benzinga
The NEXT Big Merger is Underway on the NASDAQ: JUPW Signs Definitive Agreement to Merge with Next Frontier Pharmaceuticals
December 10, 2021
Via
Get News
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
↗
December 10, 2021
Good morning, investor! It's the last day of the trading week and we're starting it with the biggest pre-market stock movers for Friday!
Via
InvestorPlace
Topics
Regulatory Compliance
Jupiter Wellness & Next Frontier Pharmaceuticals Merge, Will Expand Cannabinoid & Psychedelics Drug Development
↗
December 09, 2021
Jupiter Wellness, Inc. (NASDAQ:JUPW) announced Thursday th...
Via
Benzinga
Jupiter Wellness Signs Definitive Agreement to Merge with Next Frontier Pharmaceuticals, a Leading Drug Developer and Manufacturer of Synthetic Cannabinoid Pharmaceuticals
December 09, 2021
- Owner of SYNDROS®(dronabinol), the only US-based FDA approved CII Tetrahydrocannabinol (THC), a liquid cannabinoid used in adults to treat: Chemotherapy Induced Nausea and Vomiting (CINV) associated...
From
Jupiter Wellness, Inc.
Via
AccessWire
Topics
Cannabis
Intellectual Property
Regulatory Compliance
The NEXT Big Merger is Underway on the NASDAQ: JUPW Signs Definitive Agreement to Merge with Next Frontier Pharmaceuticals. Leading Drug Developer and Manufacturer of Synthetic Cannabinoid Pharmaceuticals: (NASDAQ: JUPW) Jupiter Wellness
December 09, 2021
Via
Viz Release
Topics
Intellectual Property
TLRY is Making waves along with this NASDAQ; JW-300 Demonstrates Efficacy in Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo Controlled Clinical Trial (NASDAQ: JUPW) Jupiter Wellness
November 17, 2021
Via
Viz Release
Topics
Cannabis
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
